Francisco Sanchez-Vega
@sanchezvegaf.bsky.social
Computational oncologist at Memorial Sloan Kettering Cancer Center. Views and posts are my own and do not represent MSK.
Reposted by Francisco Sanchez-Vega
Dr. Michael Berger, Dr. David Solit, Dr. Marc Ladanyi, & the MSK-Impact team accept the @theaacr.bsky.social Team Science Award for developing & implementing a groundbreaking next-gen sequencing platform which has enabled the comprehensive molecular characterization of over 125,000 tumors. #AACR25
April 27, 2025 at 3:20 PM
Dr. Michael Berger, Dr. David Solit, Dr. Marc Ladanyi, & the MSK-Impact team accept the @theaacr.bsky.social Team Science Award for developing & implementing a groundbreaking next-gen sequencing platform which has enabled the comprehensive molecular characterization of over 125,000 tumors. #AACR25
Reposted by Francisco Sanchez-Vega
Fascinating insights from MSK gastrointestinal medical oncologist @karunamdphd.bsky.social on the role of #Ecoli in age-dependent cell cycle entry for early onset #colorectal cancer initiation. #AACR25 @theaacr.bsky.social
April 26, 2025 at 8:47 PM
Fascinating insights from MSK gastrointestinal medical oncologist @karunamdphd.bsky.social on the role of #Ecoli in age-dependent cell cycle entry for early onset #colorectal cancer initiation. #AACR25 @theaacr.bsky.social
Beautiful weather in Barcelona to kick-off the AI in Drug Discovery and Biomedicine meeting. Thanks to @irbbarcelona.org for inviting me to present our work. #BarcelonaBiomed
March 31, 2025 at 10:32 AM
Beautiful weather in Barcelona to kick-off the AI in Drug Discovery and Biomedicine meeting. Thanks to @irbbarcelona.org for inviting me to present our work. #BarcelonaBiomed
Our new manuscript highlights distinct clinical and genomic features of patients who develop secondary rectal cancer years after being treated with radiotherapy for prostate cancer. #precisiononcology
jamanetwork.com/journals/jam...
jamanetwork.com/journals/jam...
Secondary Rectal Cancer After Radiotherapy for Prostate Cancer
This case-control study compares the tumor molecular profiles, clinical characteristics, and oncologic outcomes between patients with primary rectal cancer and patients who develop secondary rectal ca...
jamanetwork.com
March 19, 2025 at 3:49 PM
Our new manuscript highlights distinct clinical and genomic features of patients who develop secondary rectal cancer years after being treated with radiotherapy for prostate cancer. #precisiononcology
jamanetwork.com/journals/jam...
jamanetwork.com/journals/jam...